Please login to the form below

Not currently logged in
Email:
Password:

OncoVex

This page shows the latest OncoVex news and features for those working in and with pharma, biotech and healthcare.

AZ signs yet another cancer immunotherapy deal

AZ signs yet another cancer immunotherapy deal

The most advanced is Amgen's OncoVex (talimogene laherparepvec), which in 2013 became the first oncolytic virus to show efficacy in a phase III trial involving people with the skin cancer

Latest news

  • Amgen says viral melanoma therapy clears phase III trial Amgen says viral melanoma therapy clears phase III trial

    Amgen says viral melanoma therapy clears phase III trial. OncoVex demonstrates durable response in skin cancer patients. ... The melanoma immunotherapeutic - talimogene laherparepvec (also known as OncoVex) - works by introducing a virus that selectively

  • Disease focus: Melanoma

    nilotinib. In development. Vaccines. OncoVEX GM-CSF. In development. Vaccines. MAGE-A3 ASCI.

  • Amgen to buy BioVex

    BioVex's portfolio includes OncoVex (GM-CSF) – an investigational vaccine to treat melanoma and head and neck cancer. ... Philip Astley-Sparke, CEO, BioVex, also praised the agreement: "Amgen is ideally positioned to leverage the potential of OncoVEX

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics